| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Regulatory Officer
1 company
Delaet Ingrid is a Chief Regulatory Officer at NEUROCRINE BIOSCIENCES INC. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $758K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2025 | NBIX Neurocrine Biosciences Inc | Chief Regulatory Officer | Sale+OE | 457 | $135.00 | $61,695.00 | -8.8% | +3.1% | - | |
| Feb 13, 2025 | NBIX Neurocrine Biosciences Inc | Chief Regulatory Officer | Sale+OE | 1,471 | $116.71 | $171,674.12 | -14.3% | +1.6% | +6.2% | |
| Feb 3, 2025 | NBIX Neurocrine Biosciences Inc | Chief Regulatory Officer | Sale+OE | 1,045 | $150.81 | $157,594.39 | -14.2% | -26.9% | -7.4% | |
| Dec 31, 2024 | NBIX Neurocrine Biosciences Inc | Chief Regulatory Officer | Sale+OE | 272 | $138.10 | $37,563.20 | -9.8% | -19.0% | +3.9% | |
| Dec 17, 2024 | NBIX Neurocrine Biosciences Inc | Chief Regulatory Officer | Sale+OE | 1,091 | $135.00 | $147,285.00 | -30.3% | -18.4% | +3.7% | |
| Aug 13, 2024 | NBIX Neurocrine Biosciences Inc | Chief Regulatory Officer | Sale+OE | 7,143 | $150.10 | $1,072,180.44 | -43.9% | -15.6% | -12.7% | |
| Aug 6, 2024 | NBIX Neurocrine Biosciences Inc | Chief Regulatory Officer | Sale+OE | 273 | $147.70 | $40,322.10 | -4.0% | -17.2% | -11.8% | |
| Jul 16, 2024 | NBIX Neurocrine Biosciences Inc | Chief Regulatory Officer | Sale+OE | 2,857 | $150.03 | $428,627.00 | -11.7% | -21.0% | -9.5% | |
| Jul 1, 2024 | NBIX Neurocrine Biosciences Inc | Chief Regulatory Officer | Sale+OE | 272 | $138.11 | $37,565.92 | -3.5% | -17.8% | -8.6% | |
| May 31, 2024 | NBIX Neurocrine Biosciences Inc | Chief Regulatory Officer | Sale+OE | 273 | $136.55 | $37,278.15 | -3.5% | -5.2% | -9.1% |